Hasil Pencarian - A. Iurlo

  • Menampilkan 1 - 14 hasil dari 14
Perbaiki Hasil
  1. 1
    P1018: TREND OF CIRCULATING CD34+ CELLS IN MYELOFIBROSIS PATIENTS TREATED WITH RUXOLITINIB

    P1018: TREND OF CIRCULATING CD34+ CELLS IN MYELOFIBROSIS PATIENTS TREATED WITH RUXOLITINIB oleh D. Cattaneo, N. Galli, C. Bucelli, S. Artuso, A. Iurlo

    Diterbitkan 2022-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    EPISODIO DI CONTAMINAZIONE DI CAMPIONI NEL SISTEMA DI LETTURA BACTEC 460 E VERIFICA CON METODICA PFGE.

    EPISODIO DI CONTAMINAZIONE DI CAMPIONI NEL SISTEMA DI LETTURA BACTEC 460 E VERIFICA CON METODICA PFGE. oleh M. Buratta, A. Moro, A. Iurlo, T. Cassetti, L. Pasquale, T. Sposini, R. Mazzolla, F. Bistoni

    Diterbitkan 2003-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    VERIFICA DI VITALITA’ DEI BACILLI TUBERCOLARI IN PREPARATI MICROSCOPICI PER LA COLORAZIONE DI ZIEHL NEELSEN.

    VERIFICA DI VITALITA’ DEI BACILLI TUBERCOLARI IN PREPARATI MICROSCOPICI PER LA COLORAZIONE DI ZIEHL NEELSEN. oleh A. Moro, M. Buratta, A. Iurlo, T. Cassetti, L. Pasquale, T. Sposini, R. Mazzolla, F. Bistoni

    Diterbitkan 2003-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    P697: PONATINIB IN A REAL-LIFE SETTING: A RETROSPECTIVE ANALYSIS FROM THE MONITORING REGISTRIES OF THE ITALIAN MEDICINES AGENCY (AIFA)

    P697: PONATINIB IN A REAL-LIFE SETTING: A RETROSPECTIVE ANALYSIS FROM THE MONITORING REGISTRIES OF THE ITALIAN MEDICINES AGENCY (AIFA) oleh M. Breccia, P. P. Olimpieri, S. Celant, O. M. Olimpieri, F. Pane, A. Iurlo, V. Summa, P. Corradini, P. Russo

    Diterbitkan 2022-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    S152: SETD2/H3K36ME3 DEFICIENCY SUSTAINS GENOMIC INSTABILITY AND ENHANCES CLONOGENIC POTENTIAL OF CHRONIC MYELOID LEUKEMIA (CML) PROGENITORS

    S152: SETD2/H3K36ME3 DEFICIENCY SUSTAINS GENOMIC INSTABILITY AND ENHANCES CLONOGENIC POTENTIAL OF CHRONIC MYELOID LEUKEMIA (CML) PROGENITORS oleh M. Mancini, S. De Santis, C. Monaldi, S. Bruno, F. Castagnetti, G. Gugliotta, A. Iurlo, M. Cerrano, S. Galimberti, S. Balducci, F. Stagno, G. Rosti, M. Cavo, S. Soverini

    Diterbitkan 2022-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    P1050: THROMBOCYTOPENIC MYELOFIBROSIS (MF) PATIENTS PREVIOUSLY TREATED WITH A JAK INHIBITOR IN A PHASE 3 RANDOMIZED STUDY OF MOMELOTINIB (MMB) VERSUS DANAZOL (DAN) [MOMENTUM]

    P1050: THROMBOCYTOPENIC MYELOFIBROSIS (MF) PATIENTS PREVIOUSLY TREATED WITH A JAK INHIBITOR IN A PHASE 3 RANDOMIZED STUDY OF MOMELOTINIB (MMB) VERSUS DANAZOL (DAN) [MOMENTUM] oleh A. Vannucchi, R. Mesa, A. Gerds, H. K. Al-Ali, D. Lavie, A. Kuykendall, S. Grosicki, A. Iurlo, Y. T. Goh, M. Lazaroiu, M. Egyed, M. L. Fox, D. McLornan, A. Perkins, S.-S. Yoon, V. Gupta, J.-J. Kiladjian, R. Donahue, J. Kawashima, S. Verstovsek

    Diterbitkan 2022-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    S195: MOMENTUM: PHASE 3 RANDOMIZED STUDY OF MOMELOTINIB (MMB) VERSUS DANAZOL (DAN) IN SYMPTOMATIC AND ANEMIC MYELOFIBROSIS (MF) PATIENTS PREVIOUSLY TREATED WITH A JAK INHIBITOR

    S195: MOMENTUM: PHASE 3 RANDOMIZED STUDY OF MOMELOTINIB (MMB) VERSUS DANAZOL (DAN) IN SYMPTOMATIC AND ANEMIC MYELOFIBROSIS (MF) PATIENTS PREVIOUSLY TREATED WITH A JAK INHIBITOR oleh S. Verstovsek, A. Vannucchi, A. Gerds, H. K. Al-Ali, D. Lavie, A. Kuykendall, S. Grosicki, A. Iurlo, Y. T. Goh, M. Lazaroiu, M. Egyed, M. L. Fox, D. McLornan, A. Perkins, S.-S. Yoon, V. Gupta, J.-J. Kiladjian, R. Donahue, J. Kawashima, R. Mesa

    Diterbitkan 2022-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    P1706: CLINICAL UTILITY OF ONLINE MONITORING OF PATIENT-REPORTED SYMPTOMS IN NEWLY DIAGNOSED PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN REAL-LIFE PRACTICE

    P1706: CLINICAL UTILITY OF ONLINE MONITORING OF PATIENT-REPORTED SYMPTOMS IN NEWLY DIAGNOSED PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN REAL-LIFE PRACTICE oleh F. Efficace, F. Cottone, B. Yanez, F. Castagnetti, G. Caocci, M. Bonifacio, A. Patriarca, I. Capodanno, M. C. Miggiano, M. Tiribelli, M. Breccia, L. Luciano, V. Giai, A. Iurlo, E. Abruzzese, C. Fava, G. Rosti, J. Cortes, V. Kota, M. Vignetti, D. Cella

    Diterbitkan 2022-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    P995: MYELOID NEOPLASMS-ASSOCIATED GENE VARIANTS IN 639 PATIENTS WITH POST-POLYCYTHEMIA VERA AND POST-ESSENTIAL THROMBOCYTHEMIA MYELOFIBROSIS: AN ANALYSIS OF THE MYSEC COHORT

    P995: MYELOID NEOPLASMS-ASSOCIATED GENE VARIANTS IN 639 PATIENTS WITH POST-POLYCYTHEMIA VERA AND POST-ESSENTIAL THROMBOCYTHEMIA MYELOFIBROSIS: AN ANALYSIS OF THE MYSEC COHORT oleh B. Mora, P. Guglielmelli, A. Kuykendall, M. Maffioli, G. Rotunno, R. S. Komrokji, F. Palandri, J.-J. Kiladjian, A. Iurlo, G. Auteri, D. Cattaneo, V. De Stefano, S. Salmoiraghi, T. Devos, F. Cervantes, M. Merli, A. Campagna, G. Benevolo, M. Brociner, F. Albano, J. Gotlib, M. Caramella, M. Ruggeri, D. M. Ross, F. Orsini, C. Pessina, I. Colugnat, F. Pallotti, T. Barbui, L. Bertù, M. G. Della Porta, A. M. Vannucchi, F. Passamonti

    Diterbitkan 2022-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    P698: BOSUTINIB DOSE OPTIMIZATION IN THE SECOND-LINE TREATMENT OF ELDERLY CML PATIENTS: EXTENDED 3-YEAR FOLLOW-UP AND FINAL RESULTS OF THE BEST STUDY

    P698: BOSUTINIB DOSE OPTIMIZATION IN THE SECOND-LINE TREATMENT OF ELDERLY CML PATIENTS: EXTENDED 3-YEAR FOLLOW-UP AND FINAL RESULTS OF THE BEST STUDY oleh F. Castagnetti, M. Bocchia, E. Abruzzese, I. Capodanno, M. Bonifacio, G. Rege Cambrin, M. Crugnola, G. Binotto, C. Elena, A. Lucchesi, M. Bergamaschi, F. Albano, L. Luciano, F. Sorà, F. Lunghi, F. Stagno, M. Cerrano, A. Iurlo, A. R. Scortechini, S. Leonetti Crescenzi, R. Spadano, E. Trabacchi, M. Lunghi, G. Spinosa, D. Ferrero, D. Rapezzi, M. Ladetto, L. Nocilli, G. Gugliotta, M. Iezza, M. Cavo, G. Saglio, F. Pane, G. Rosti

    Diterbitkan 2022-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    Treatment discontinuation following low-dose TKIs in 248 chronic myeloid leukemia patients: Updated results from a campus CML real-life study

    Treatment discontinuation following low-dose TKIs in 248 chronic myeloid leukemia patients: Updated results from a campus CML real-life study oleh A. Iurlo, D. Cattaneo, D. Cattaneo, D. Consonni, F. Castagnetti, M. C. Miggiano, G. Binotto, M. Bonifacio, G. Rege-Cambrin, M. Tiribelli, F. Lunghi, A. Gozzini, P. Pregno, E. Abruzzese, I. Capodanno, C. Bucelli, M. Pizzuti, S. Artuso, M. Iezza, E. Scalzulli, G. La Barba, A. Maggi, S. Russo, C. Elena, A. R. Scortechini, A. Tafuri, R. Latagliata, G. Caocci, M. Bocchia, S. Galimberti, L. Luciano, C. Fava, R. Foà, G. Saglio, G. Rosti, M. Breccia

    Diterbitkan 2023-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    P1010: RUXOLITINIB IN MYELODEPLETIVE MYELOFIBROSIS: RESPONSE, TOXICITY, AND OUTCOME

    P1010: RUXOLITINIB IN MYELODEPLETIVE MYELOFIBROSIS: RESPONSE, TOXICITY, AND OUTCOME oleh F. Palandri, D. Bartoletti, M. Breccia, G. Auteri, E. M. Elli, M. M. Trawinska, N. Polverelli, M. Tiribelli, G. Benevolo, A. Iurlo, A. Tieghi, F. H. Heidel, G. Caocci, E. Beggiato, G. Binotto, F. Cavazzini, M. Miglino, C. Bosi, M. Crugnola, M. Bocchia, B. Martino, N. Pugliese, A. D. Romagnoli, C. Mazzoni, L. Scaffidi, A. Isidori, D. Cattaneo, M. Krampera, F. Pane, D. Cilloni, G. Semenzato, R. M. Lemoli, A. Cuneo, E. Abruzzese, N. Vianelli, M. Cavo, M. Bonifacio, G. A. Palumbo

    Diterbitkan 2022-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    P1011: PREDICTORS OF COVID-19 DISEASE AND SURVIVAL TO COVID-19 IN MPN PATIENTS TREATED WITH RUXOLITINIB

    P1011: PREDICTORS OF COVID-19 DISEASE AND SURVIVAL TO COVID-19 IN MPN PATIENTS TREATED WITH RUXOLITINIB oleh F. Palandri, D. Bartoletti, E. M. Elli, G. Auteri, M. Bonifacio, G. Benevolo, F. Heidel, M. M. Trawinska, E. Rossi, C. Bosi, A. Tieghi, M. Tiribelli, A. Iurlo, N. Polverelli, G. Caocci, G. Binotto, F. Cavazzini, E. Beggiato, D. Cilloni, C. Tatarelli, F. Mendicino, M. Miglino, M. Bocchia, M. Crugnola, C. Mazzoni, A. D. Romagnoli, G. Rindone, S. Ceglie, A. D’Addio, E. Santoni, D. Cattaneo, R. M. Lemoli, M. Krampera, A. Cuneo, G. Semenzato, R. Latagliata, E. Abruzzese, N. Vianelli, M. Cavo, A. Andriani, V. De Stefano, G. Palumbo, M. Breccia

    Diterbitkan 2022-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  14. 14
    P1009: PREDICTORS OF HOSPITALIZATION AND SEVERE OUTCOMES IN PATIENTS WITH MPN AND COVID-19

    P1009: PREDICTORS OF HOSPITALIZATION AND SEVERE OUTCOMES IN PATIENTS WITH MPN AND COVID-19 oleh T. Barbui, A. Carobbio, A. Masciulli, A. Iurlo, M. A. Sobas, E. M. Elli, E. Rumi, V. De Stefano, F. Lunghi, M. Marchetti, R. Daffini, M. Gasior Kabat, B. Cuevas, M. L. Fox, M. M. Andrade Campos, F. Palandri, P. Guglielmelli, G. Benevolo, C. Harrison, M. A. Foncillas, M. Bonifacio, A. Alvarez-Larran, J.-J. Kiladjian, E. Bolanos Calderon, A. Patriarca, K. S. Quiroz Cervantes, M. Griesshammer, V. Garcia-Gutierrez, A. Marin Sanchez, E. Magro Mazo, M. Ruggeri, J. C. Hernandez-Boluda, S. Osorio, G. Carreno-Tarragona, M. Sagues Serrano, R. Kusec, B. Navas Elorza, A. Angona, B. Xicoy Cirici, E. Lopez Abadia, S. Koschmieder, E. Cichocka, A. Kulikowska de Nałęcz, M. Bellini, D. Cattaneo, C. Bucelli, F. Cavalca, O. Borsani, S. Betti, N. Curto-Garcia, S. Carbonell, L. Benajiba, A. Rambaldi, A. M. Vannucchi

    Diterbitkan 2022-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: